Evidence map›Paper›PMID 34775606›Full record

ArticleImmunology2022

Diverse myeloid cells are recruited to the developing and inflamed mammary gland.

Gillian J Wilson, Ayumi Fukuoka, Francesca Vidler, Gerard J Graham

Abstract read
In one paragraph

Article in Immunology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Immune Cell Contribution to Mammary Gland Development.Journal of mammary gland biology and neoplasia · 2024
    Review
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Gillian J WilsonChemokine Research Group, Institute of Infection, Immunity and Inflammation, University of Glasgow, Glasgow, UK.ORCID 0000-0002-9513-8437
Ayumi FukuokaChemokine Research Group, Institute of Infection, Immunity and Inflammation, University of Glasgow, Glasgow, UK.
Francesca VidlerChemokine Research Group, Institute of Infection, Immunity and Inflammation, University of Glasgow, Glasgow, UK.
Gerard J GrahamChemokine Research Group, Institute of Infection, Immunity and Inflammation, University of Glasgow, Glasgow, UK.

Funding

Medical Research Council MR/M019764/1Medical Research Council MR/V010972/1Medical Research Council MRV0109721Wellcome TrustWellcome Trust 099251/Z/12/Z
6 · The paper itself

Abstract

The immune system plays fundamental roles in the mammary gland, shaping developmental processes and controlling inflammation during infection and cancer.Here, we reveal unanticipated heterogeneity in the myeloid cell compartment duringdevelopment of virgin, pregnant, lactating and involuting mouse mammary glands,and in milk. We investigate the functional consequences of individual and compoundchemokine receptor deficiency on cell recruitment. Diverse myeloid cell recruitmentwas also shown in models of sterile inflammation and bacterial infection.Strikingly, we have shown that inflammation and infection can alter the abundanceof terminal end buds, a key developmental structure, within the pubertal mammarygland. This previously unknown effect of inflammatory burden during puberty couldhave important implications for understanding pubertal development.

Indexed as

Disease SusceptibilityAnimalsBiomarkersBiopsyCellular MicroenvironmentCytokinesDisease Models, AnimalFemaleFlow CytometryGranulocytesImmunohistochemistryMacrophagesMammary Glands, AnimalMastitisMiceMonocytesBiomarkersCytokineschemokinedevelopmentinflammationmammarymyeloid

Identifiers

PMID34775606
PMCPMC10357480

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.